+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H+-ATPase expression and activity

Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H+-ATPase expression and activity

Oncology Letters 15(5): 7279-7290

Vacuolar H+-ATPase (V-ATPase) serves a key role in adjusting and maintaining the intracellular pH, as well as in regulating the drug resistance of tumor cells. In recent years, the expression level of V-ATPase has been considered to be able to predict the sensitivity of breast cancer cells to chemotherapy drugs. Cluster of differentiation 147 (CD147) is known to serve a key role in the development and progression of breast cancer. The present study aimed to identify the role CD147 and V-ATPase in chemoresistance in breast cancer, and to characterize the regulation of CD147 on V-ATPase. Firstly, the expression levels of CD147 and V-ATPase were detected in chemotherapy-resistance breast cancer samples. It was demonstrated that V-ATPase was highly expressed in chemotherapy-resistance breast cancer samples, and that its expression was correlated with CD147 expression. Subsequently, MCF-7 and MDA-MB-231 cells were used to study the regulatory effect of CD147 on the expression and function of V-ATPase. Gene transfection or small interfering RNA transfection were used to control the expression of CD147 in the two cell lines. The results revealed that the overexpression of CD147 increased the expression of V-ATPase in MCF-7 cells, whereas CD147 knockdown decreased V-ATPase expression in MDA-MB-231 cells. It was also observed that CD147 affected the V-ATPase activity, regulating the transmembrane pH gradient of cancer cells. These results demonstrated that CD147 was associated with the sensitivity of chemotherapeutic drugs of epirubicin and docetaxel, while pantoprazole was able to partially reverse the CD147-mediated chemoresistance in breast cancer. Therefore, the current study provided a possible mechanism for further examination of drug resistance in breast cancer.

(PDF emailed within 0-6 h: $19.90)

Accession: 055116117

Download citation: RISBibTeXText

PMID: 29731886

DOI: 10.3892/ol.2018.8199

Related references

CD147 mediates chemoresistance in breast cancer via ABCG2 by affecting its cellular localization and dimerization. Cancer Letters 337(2): 285-292, 2013

Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer. International Journal of Cancer 133(4): 843-854, 2013

The glycolytic enzyme aldolase mediates assembly, expression, and activity of vacuolar H+-ATPase. Journal of Biological Chemistry 279(10): 8732-8739, 2003

Ginsenoside Rh2 differentially mediates microRNA expression to prevent chemoresistance of breast cancer. Asian Pacific Journal of Cancer Prevention 16(3): 1105-1109, 2015

Plasma soluble cluster of differentiation 147 levels are increased in breast cancer patients and associated with lymph node metastasis and chemoresistance. Hong Kong Medical Journal, 2018

Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. American Journal of Physiology. Cell Physiology 286(6): C1443-C1452, 2004

LASS2/TMSG1 inhibits growth and invasion of breast cancer cell in vitro through regulation of vacuolar ATPase activity. Tumour Biology 36(4): 2831-2844, 2015

The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells. Journal of Biological Chemistry 288(45): 32731-32741, 2014

PED mediates AKT-dependent chemoresistance in human breast cancer cells. Cancer Research 65(15): 6668-6675, 2005

Isolation of vacuolar membrane H(+)-ATPase-deficient yeast mutants; the VMA5 and VMA4 genes are essential for assembly and activity of the vacuolar H(+)-ATPase. Journal of Biological Chemistry 268(1): 221-227, 1993

Differentiation-dependent expression of vacuolar H+-ATPase B1 promoter. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 590A, Sept, 1998

Expression of vacuolar H(+)-ATPase in mouse osteoclasts during in vitro differentiation. American Journal of Physiology 263(2 Pt 2): F277-F283, 1992

miR-760 mediates chemoresistance through inhibition of epithelial mesenchymal transition in breast cancer cells. European Review for Medical and Pharmacological Sciences 20(23): 5002-5008, 2017

miR-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer. Cancer Science: -, 2018

Expression of vacuolar proton atpase in mouse osteoclasts during in vitro differentiation. American Journal of Physiology 263(2 PART 2): F277-F283, 1992